Richard Gaster
InvestorManaging Partner at venBio Partners
San Francisco, California
Writes $20M β $30M checks Β· typically $25M
About
Richard Gaster combines Harvard-affiliated plastic surgery training and experience as a cancer dad with translational medicine leadership at Pliant, focusing on mechanistically novel aging, CNS, and metabolic disease approaches.
Invests in
BiotechHealthtech
Experience
- venBio PartnersManaging Partnercurrent2017 β presentSan Francisco Bay Area
- Oak Hill BioBoard Membercurrent2026 β present
- Pediatric Brain Tumor FoundationBoard Membercurrent2026 β present
- MyoventiveBoard Membercurrent2025 β present
- Entact BioBoard Membercurrent2021 β present
- AttralusBoard Membercurrent2020 β present
- Arrakis TherapeuticsBoard Membercurrent2019 β presentGreater Boston
- Aeovian PharmaceuticalsBoard Membercurrent2019 β present
- NorthSea Therapeutics B.V.Board Membercurrent2020 β present
- Yarrow BioscienceBoard Observer2025 β 2026
- 35PharmaBoard Member2022 β 2026
- AlumisBoard Member2024
- ACELYRIN, INC.Board Member2021 β 2023
- Ventyx BiosciencesBoard Member2021 β 2023
- PharvarisBoard Member2019 β 2021The Randstad, Netherlands
- Harmony BiosciencesBoard Observer2017 β 2020
- Akero TherapeuticsBoard Observer2018 β 2019
- Pliant TherapeuticsHead of Translational Medicine2016 β 2017
- Third Rock VenturesSenior Associate2015 β 2016Boston, Massachusetts
- wearBiΕFounder & Inventor2013 β 2016
Education
- Stanford University School of MedicineDoctor of Medicine (M.D.), Medical Scientist Training Program (MSTP)2006 β 2013
- Harvard Medical SchoolPlastic and Reconstructive Surgery Resident Physician2013 β 2015
- Stanford UniversityDoctor of Philosophy (Ph.D.), Bioengineering2007 β 2012
- University of PennsylvaniaBSE, Bioengineering2002 β 2006
- Buckley
Skills & more
Biomedical Engineering29Molecular Biology21Cancer20Medical Devices14Microfluidics5Nanotechnology10Biotechnology17Fluorescence Microscopy5PCR5Lifesciences10Microscopy7Surgery4
+10 more
Flow CytometryCellCell BiologyResearchLife SciencesNeuroscienceClinical ResearchMedicinePoint-of-Care DiagnosticsReserachFrom Richard's professional profile.
Same school
Also attended Stanford University School of Medicine67
Jeffrey FinerVenture Partner at Third Rock VenturesRebecca MancusiInvestor at Third Rock VenturesSebastian CaliriInvestment Team at 8VCAlex MorganInvestor at Khosla VenturesLauren PopovAssociate at Westlake Village BioPartnersClare OzawaManaging Director at Versant Ventures
+ 61 more
Also attended Harvard Medical School113
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 107 more
Also attended Stanford University1,575
Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital
+ 1,569 more
Also attended University of Pennsylvania607
Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark CapitalKerry KilleenAssociate General Counsel at Revolution
+ 601 more
Shared employers
Also worked at Arrakis Therapeutics6
Alan WaltsVenture Partner at Advent Life SciencesNiresh BerinpanathanPrincipal at Nextech InvestJakob LovenPartner at Nextech InvestFiona MacLaughlinVice President, Venture Investments at Johnson & Johnson Innovation β JJDCMichelle DoigPartner at Omega FundsChristopher O'DonnellPartner at Pfizer Venture Investments
Also worked at Aeovian Pharmaceuticals2
Also worked at Yarrow Bioscience1
Also worked at Pharvaris1
Deals Β· 2
Aeovian PharmaceuticalsBoard seat
via venBio Partners Β· filed Dec 2025 Β· $55M raise
14ner OncologyBoard seat
via venBio Partners Β· filed Nov 2020 Β· $65M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at venBio Partners
Aaron Royston
Managing Partner at venBio Partners
Corey Goodman
Co-founder and Managing Partner at venBio Partners
Daniel Teichmann
Controller at venBio Partners
David Pezeshki
Chief Financial Officer at venBio Partners
Jaume Pons
Venture Partner at venBio Partners
Parthiv Patel
Analyst at venBio Partners
Robert Adelman
Co-founder and Emeritus Managing Partner at venBio Partners
Yvonne Yamanaka
Partner at venBio Partners
Network1
Investors connected to Richard in public investor directories β a warm-intro map.






.png)






























